Loading insider details...
Beta
Latest Form 4 (Aug 19, 2026): Exercise/Conversion of 26,250 STOK shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 19, 2026 | Stoke Therapeutics, Inc. (STOK) | Exercise/Conversion | 26,250 | n/a |
| Jul 16, 2026 | CYTOKINETICS INC (CYTK) | Grant/Award | 151 | $12.5K |
| Jun 5, 2026 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 17,786 | n/a |
| Jun 1, 2026 | CYTOKINETICS INC (CYTK) | Sale | 2,933 | $223.2K |
| May 27, 2026 | CYTOKINETICS INC (CYTK) | Grant/Award | 2,851 | n/a |
| Apr 15, 2026 | CYTOKINETICS INC (CYTK) | Grant/Award | 191 | $12.5K |
| Mar 17, 2026 | Stoke Therapeutics, Inc. (STOK) | Exercise/Conversion | 35,500 | n/a |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | Disposition to Issuer | 6,692 | n/a |
| Jan 16, 2026 | CYTOKINETICS INC (CYTK) | Grant/Award | 197 | $12.5K |
| Dec 10, 2025 | Stoke Therapeutics, Inc. (STOK) | Sale | 3,825 | $120.3K |